Columns

Columns

8th Participation in DISC Business with Miniaturized HTS as a Bridge
Kenji Wakabayashi, Ph.D. (Vice President, Biological Research Department, Daiichi Sankyo RD Novare Co., LTD.)
7th Cell Therapy and Drug Discovery Research based on Next-Generation Gene Transfer Technology / Artificial Chromosome Vectors
Yasuhiro Kazuki, Ph.D. (Associate Professor, Department of Biomedical Science, Institute of Regenerative Medicine and Biofunction, Graduate School of Medical Science, Tottori University, Chromosome Engineering Research Center (CERC) Director, Tottori Pharmaceutical Innovation Center (TPIC) )
6th Challenges to "Reverse Value Generation" Drug Discovery
Hiroshi Nagabukuro, Ph.D. (COO/CSO, ARTham Therapeutic/ Adjunct Professor, Oita University, Faculty of Medicine, Department of Clinical Pharmacology & Therapeutics)
5th Small Biotech with a Big Vision
Masaaki Sawa, Ph.D. (Chief Scientific Officer, CARNA BIOSCIENCES, INC.)
4th Development of Nasal Drug Delivery System = Translational Research Business
Shuichi Kanazashi, Ph.D. (President, Shin Nippon Biomedical Laboratories, Ltd.)
3rd SEND, FDA, and Industry Movement
Takayuki ANZAI (Professor (AP), Showa University, School of Medicine)
2nd Drug Discovery in Academia – Initiatives by NIBIOHN
Yoshihiro Yoneda (Director General, National Institutes of Biomedical Innovation, Health and Nutrition)
1st Aspiring to be a Navigator of Innovative Drug Discovery Development
Noriatsu KONO (Managing Director, Department of Innovative Drug Discovery and Development, Japan Agency for Medical Research and Development)

Page TOP